4.2 Article

Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development

Journal

IMMUNOLOGICAL INVESTIGATIONS
Volume 41, Issue 6-7, Pages 658-679

Publisher

TAYLOR & FRANCIS INC
DOI: 10.3109/08820139.2012.689591

Keywords

MWSC; Gliomas; IL4R alpha; Arginase; TAM; Malignancy; Immunosuppression; CD11b; Gr1

Categories

Funding

  1. National Institutes of Health [2R01NS055140, 2P01 NS40923, 1P01CA132714, P3CA047904]
  2. Musella Foundation

Ask authors/readers for more resources

Myeloid derived suppressor cells (MDSCs) are a heterogeneous population of cells that inhibit anti-tumor immunity through a variety of mechanisms. Malignant gliomas are heavily infiltrated by myeloid cells, some of which appear to share biological functions of MDSCs. Our data with mouse de novo gliomas indicate critical roles of these cells in glioma development. This review summarizes the current understanding of MDSC biology in gliomas and discusses therapeutic interventions that can safely reverse the suppressive effects of MDSCs. The insight gained from these findings may lead to the development of novel immunotherapeutic strategies for gliomas.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available